Arbutus Biopharma Corporation · NASDAQ:ABUS

Roivant Sciences Ltd. reported a 20.50% stake in Arbutus Biopharma Corporation (Schedule 13D/A)

Event Feb 18, 2025 · Filed Feb 18, 2025

Roivant Sciences Ltd. reported a 20.50% stake in Arbutus Biopharma Corporation, 38,847,462 shares, with active intent on Feb 18, 2025. Filed Feb 18, 2025 (Schedule 13D/A).

Stake
20.50%
Shares
38,847,462
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
Roivant Sciences Ltd.20.50%38,847,462

Source

View original at SEC

Related